[Current place of anticoagulants, fibrinolytic and anti-aggregation agents in the prevention of thrombosis].

M. Bousser,M. Samama

1973-11-01

Abstract:

What problem does this paper attempt to address?

Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey

Gerlando Natalello,Silvia Laura Bosello,Corrado Campochiaro,Giuseppina Abignano,Maria De Santis,Arianna Ferlito,Duygu Temiz Karadağ,Angela Anna Padula,Giulio Cavalli,Maria Antonietta D'Agostino,Carlo Selmi,Marco Matucci-Cerinic,Lorenzo Dagna,Giacomo De Luca

DOI: https://doi.org/10.1002/acr2.11627

Abstract:Objective: Systemic sclerosis (SSc) is an orphan disease that can lead to severe involvement of the gastrointestinal tract with a significant impact on patients' quality of life (QoL). The Mediterranean diet (MD) was consistently demonstrated to have beneficial effects on chronic diseases based on biological bases. We aimed to evaluate the adherence to the MD of Italian patients with SSc to preliminarily assess its association with gastrointestinal symptoms and other disease features, mood, and QoL. Methods: In this cross-sectional study, adherence to the MD was measured in 387 patients from four SSc Italian referral centers through the 14-item Mediterranean Diet Adherence Screener (14-MEDAS) questionnaire. We also registered patients' reported outcomes related to the QoL and mood. Results: Overall, an optimal adherence to MD was observed in 14.7% of patients with SSc, a moderate adherence in 71.3%, and a low adherence in 14.0%. In univariate analysis, poor adherence to the MD was associated with a more prominent depressive mood, time missed at work, and perception of more severe Raynaud's phenomenon and digital ulcers, whereas the 14-MEDAS score inversely correlated with depression score and reflux. Conclusion: In our cohort of patients with SSc, overall adherence to MD was moderate. Patients with lower adherence to MD also reported worse outcomes related to QoL and mood. Administration of the 14-MEDAS could be a reasonable choice to assess adherence to the MD in patients with SSc. Future initiatives to study the role of MD in the management of patients with SSc are warranted.
Metabolic syndrome in systemic lupus erythematosus patients under Mediterranean diet

Sara DelOlmo-Romero,Irene Medina-Martínez,Rocio Gil-Gutierrez,Gabriela Pocovi-Gerardino,María Correa-Rodríguez,Norberto Ortego-Centeno,Blanca Rueda-Medina

DOI: https://doi.org/10.1016/j.medcli.2023.10.009

2024-03-22

Abstract:Background and aims: Metabolic syndrome (MetS) is a chronic proinflammatory and prothrombotic condition that exacerbates insulin resistance, oxidative damage, and cardiovascular risk, being more prevalent in patients with systemic lupus erythematosus (SLE), a chronic multisystemic autoimmune disorder. This study aim was to determine the prevalence of MetS and associations with SLE clinical characteristics, cardiovascular risk and dietary pattern in a population of Spanish SLE patients. Design and methods: Cross-sectional study of 293 patients was conducted (90.4% females; mean age 46.8 (12.94)). The diagnosis of MetS was established based on the criteria of the National Cholesterol Education Program Adult Treatment Panel III. SLE Disease Activity Index (SLEDAI-2K) and SDI Damage Index were used to assess disease activity and disease-related damage, respectively. Med Diet adherence was assessed through a 14 items questionnaire on food consumption frequency and habits. Results: MetS was present in 15% SLE patients. Triglycerides, high-density lipoprotein cholesterol, systolic blood pressure and waist circumference were significantly increased (p<0.001) in the group of MetS patients. Patients with MetS showed significantly increased SDI damage index (1.70 (1.69) vs 0.88 (1.12), p<0.001) and complement C3 level (118.70 (32.67) vs 107.55 (26.82), p=0.011). No significant differences were observed according to Med Diet adherence level. Conclusion: We observed a lower prevalence of MetS in SLE than that reported in previous studies, which may be a result of the good level of adherence to the MedDiet in our study sample. Additionally, MetS was associated with higher SDI and complement C3 levels but no with medication use.
Mortality risk factors in primary Sjögren syndrome: a real-world, retrospective, cohort study

Pilar Brito-Zerón,Alejandra Flores-Chávez,Ildiko Fanny Horváth,Astrid Rasmussen,Xiaomei Li,Peter Olsson,Arjan Vissink,Roberta Priori,Berkan Armagan,Gabriela Hernandez-Molina,Sonja Praprotnik,Luca Quartuccio,Nevsun Inanç,Burcugül Özkızıltaş,Elena Bartoloni,Agata Sebastian,Vasco C Romão,Roser Solans,Sandra G Pasoto,Maureen Rischmueller,Carlos Galisteo,Yasunori Suzuki,Virginia Fernandes Moça Trevisani,Cecilia Fugmann,Andrés González-García,Francesco Carubbi,Ciprian Jurcut,Toshimasa Shimizu,Soledad Retamozo,Fabiola Atzeni,Benedikt Hofauer,Sheila Melchor-Díaz,Tamer Gheita,Miguel López-Dupla,Eva Fonseca-Aizpuru,Roberto Giacomelli,Marcos Vázquez,Sandra Consani,Miriam Akasbi,Hideki Nakamura,Antónia Szántó,A Darise Farris,Li Wang,Thomas Mandl,Angelica Gattamelata,Levent Kilic,Katja Perdan Pirkmajer,Kerem Abacar,Abdurrahman Tufan,Salvatore de Vita,Hendrika Bootsma,Manuel Ramos-Casals,Sjögren Big Data Consortium,S Arends,E Treppo,S Longhino,V Manfrè,M Rizzo,C Baldini,S Bombardieri,M Bandeira,M Silvéiro-António,R Seror,X Mariette,G Nordmark,D Danda,P Wiland,R Gerli,S K Kwok,S H Park,M Kvarnstrom,M Wahren-Herlenius,S Downie-Doyle,D Sene,D Isenberg,V Valim,V Devauchelle-Pensec,A Saraux,J Morel,C Morcillo,P E Díaz Cuiza,B E Herrera,L González-de-Paz,A Sisó-Almirall

DOI: https://doi.org/10.1016/j.eclinm.2023.102062

IF: 15.1

2023-07-04

EClinicalMedicine

Abstract:Background: What baseline predictors would be involved in mortality in people with primary Sjögren syndrome (SjS) remains uncertain. This study aimed to investigate the baseline characteristics collected at the time of diagnosis of SjS associated with mortality and to identify mortality risk factors for all-cause death and deaths related to systemic SjS activity measured by the ESSDAI score. Methods: In this international, real-world, retrospective, cohort study, we retrospectively collected data from 27 countries on mortality and causes of death from the Big Data Sjögren Registry. Inclusion criteria consisted of fulfilling 2002/2016 SjS classification criteria, and exclusion criteria included chronic HCV/HIV infections and associated systemic autoimmune diseases. A statistical approach based on a directed acyclic graph was used, with all-cause and Sjögren-related mortality as primary endpoints. The key determinants that defined the disease phenotype at diagnosis (glandular, systemic, and immunological) were analysed as independent variables. Findings: Between January 1st, 2014 and December 31, 2023, data from 11,372 patients with primary SjS (93.5% women, 78.4% classified as White, mean age at diagnosis of 51.1 years) included in the Registry were analysed. 876 (7.7%) deaths were recorded after a mean follow-up of 8.6 years (SD 7.12). Univariate analysis of prognostic factors for all-cause death identified eight Sjögren-related variables (ocular and oral tests, salivary biopsy, ESSDAI, ANA, anti-Ro, anti-La, and cryoglobulins). The multivariate CPH model adjusted for these variables and the epidemiological features showed that DAS-ESSDAI (high vs no high: HR = 1.68; 95% CI, 1.27-2.22) and cryoglobulins (positive vs negative: HR = 1.72; 95% CI, 1.22-2.42) were independent predictors of all-cause death. Of the 640 deaths with available information detailing the specific cause of death, 14% were due to systemic SjS. Univariate analysis of prognostic factors for Sjögren-cause death identified five Sjögren-related variables (oral tests, clinESSDAI, DAS-ESSDAI, ANA, and cryoglobulins). The multivariate competing risks CPH model adjusted for these variables and the epidemiological features showed that oral tests (abnormal vs normal results: HR = 1.38; 95% CI, 1.01-1.87), DAS-ESSDAI (high vs no high: HR = 1.55; 95% CI, 1.22-1.96) and cryoglobulins (positive vs negative: HR = 1.52; 95% CI, 1.16-2) were independent predictors of SjS-related death. Interpretation: The key mortality risk factors at the time of SjS diagnosis were positive cryoglobulins and a high systemic activity scored using the ESSDAI, conferring a 2-times increased risk of all-cause and SjS-related death. ESSDAI measurement and cryoglobulin testing should be considered mandatory when an individual is diagnosed with SjS. Funding: Novartis.
Lower Multiple Sclerosis Severity Score Is Associated with Higher Adherence to Mediterranean Diet in Subjects with Multiple Sclerosis from Northwestern Italy

Matteo Bronzini,Alessandro Maglione,Rachele Rosso,Federica Masuzzo,Manuela Matta,Raffaella Meroni,Simona Rolla,Marinella Clerico

DOI: https://doi.org/10.3390/nu16060880

IF: 5.9

2024-03-19

Nutrients

Abstract:The Mediterranean Diet (MD) is described in the literature as a beneficial dietary pattern for neurodegenerative diseases such as Multiple Sclerosis (MS). The objective of this study was to evaluate the dietary habits in people with MS (pwMS) and to test whether adherence to the MD could have an impact on the severity of the disease measured as the MS severity score (MSSS). Adherence to the MD was assessed in 31 PwMS using the Mediterranean Diet Adherence Screener (MEDAS), the Pyramid-based Mediterranean Diet Score (PyrMDS) index, and the Italian Mediterranean Index (IMI), and their eating habits were recorded in a food diary for a one-year follow-up. When data obtained from dietary analysis were compared to the MSSS, results showed that pwMS with lower MSSS adhere more to the MD than the other pwMS groups according to the MEDAS index. Furthermore, a high consumption of fiber in the MS mild severity class was observed. Further studies are needed to clarify which of the nutritional components of the MD may impact the course of MS and if the sensitization of pwMS to MD adherence can be a strategy for mitigating the disease.

nutrition & dietetics
Adherence to Mediterranean diet and subjective cognitive function in men

Ambika Bhushan,Elinor Fondell,Alberto Ascherio,Changzheng Yuan,Francine Grodstein,Walter Willett

DOI: https://doi.org/10.1007/s10654-017-0330-3

2018-01-01

European Journal of Epidemiology

Abstract:Benefits of a Mediterranean diet for cognition have been suggested, but epidemiologic studies have been relatively small and of limited duration. To prospectively assess the association between long-term adherence to a Mediterranean dietary pattern and self-reported subjective cognitive function (SCF). Prospective observational study. The Health Professionals’ Follow-up Study, a prospective cohort of 51,529 men, 40–75 years of age when enrolled in 1986, of whom 27,842 were included in the primary analysis. Mediterranean diet (MD) score, computed from the mean of five food frequency questionnaires, assessed every 4 years from 1986 to 2002. Self-reported SCF assessed by a 6-item questionnaire in 2008 and 2012, and validated by association with genetic variants in apolipoprotein-4. Using the average of 2008 and 2012 SCF scores, 38.0% of men were considered to have moderate memory scores and 7.3% were considered to have poor scores. In a multivariate model, compared with men having a MD score in the lowest quintile, those in the highest quintile had a 36% lower odds of a poor SCF score (odds ratio 0.64, 95% CI 0.55–0.75; P, trend < 0.001) and a 24% lower odds of a moderate SCF score (OR 0.76, 95% CI 0.70–0.83; P, trend < 0.001). Both remote and more recent diet contributed to this relation. Associations were only slightly weaker using baseline dietary data and a lag of 22 years. Long-term adherence to the Mediterranean diet pattern was strongly related to lower subjective cognitive function. These findings provide further evidence that a healthy dietary pattern may prevent or delay cognitive decline.
Vitamin D in Primary Sjogren's Syndrome (pSS) and the Identification of Novel Single-Nucleotide Polymorphisms Involved in the Development of pSS-Associated Diseases

Siarhei A. Dabravolski,Alexey V. Churov,Irina A. Starodubtseva,Dmitry F. Beloyartsev,Tatiana I. Kovyanova,Vasily N. Sukhorukov,Nikolay A. Orekhov

DOI: https://doi.org/10.3390/diagnostics14182035

IF: 3.6

2024-09-15

Diagnostics

Abstract:Sjögren's syndrome (SS) is a chronic autoimmune disorder characterised by lymphocytic infiltration of the exocrine glands, which leads to dryness of the eyes and mouth; systemic manifestations such as arthritis, vasculitis, and interstitial lung disease; and increased risks of lymphoma and cardiovascular diseases. SS predominantly affects women, with a strong genetic component linked to sex chromosomes. Genome-wide association studies (GWASs) have identified numerous single-nucleotide polymorphisms (SNPs) associated with primary SS (pSS), revealing insights into its pathogenesis. The adaptive and innate immune systems are crucial to SS's development, with viral infections implicated as environmental triggers that exacerbate autoimmune responses in genetically susceptible individuals. Moreover, recent research has highlighted the role of vitamin D in modulating immune responses in pSS patients, suggesting its potential therapeutic implications. In this review, we focus on the recently identified SNPs in genes like OAS1, NUDT15, LINC00243, TNXB, and THBS1, which have been associated with increased risks of developing more severe symptoms and other diseases such as fatigue, lymphoma, neuromyelitis optica spectrum disorder (NMOSD), dry eye syndrome (DES), and adverse drug reactions. Future studies should focus on larger, multi-ethnic cohorts with standardised protocols to validate findings and identify new associations. Integrating genetic testing into clinical practise holds promise for improving SS management and treatment strategies, enabling personalised interventions based on comprehensive genetic profiles. By focusing on specific SNPs, vitamin D, and their implications, future research can lead to more effective and personalised approaches for managing pSS and its complications.

medicine, general & internal
Factors associated with severe dry eye in primary Sjögren's syndrome diagnosed patients

Mónica Fernandez Castro,Carlos Sánchez-Piedra,Jose Luis Andreu,Víctor Martínez Taboada,Alejandro Olivé,Jose Rosas,SJOGRENSER Group, part of the Spanish Society of Rheumatology Systemic Autoimmune Diseases Study Group (EASSER)

DOI: https://doi.org/10.1007/s00296-018-4013-5

Abstract:Introduction: Primary Sjögren's syndrome (pSS) is an autoimmune disease, characterized by lymphocytic infiltration of exocrine glands and other organs, resulting in dry eye, dry mouth and extraglandular systemic findings. Objective: To explore the association of severe or very severe dry eye with extraocular involvement in patients diagnosed with primary Sjögren's syndrome. Methods: SJOGRENSER registry is a multicenter cross-sectional study of pSS patients. For the construction of our main variable, severe/very severe dry eye, we used those variables that represented a degree 3-4 of severity according to the 2007 Dry Eye Workshop classification. First, bivariate logistic regression models were used to identify the effect of each independent variable on severe/very severe dry eye. Secondly, multivariate analysis using regression model was used to establish the independent effect of patient characteristics. Results: Four hundred and thirty-seven patients were included in SJOGRENSER registry; 94% of the patients complained of dry eye and 16% developed corneal ulcer. Schirmer's test was pathological in 92% of the patients; 378 patients presented severe/very severe dry eye. Inflammatory articular involvement was significantly more frequent in patients with severe/very severe dry eye than in those without severe/very severe dry eye (82.5 vs 69.5%, p = 0,028). Inflammatory joint involvement was associated with severe/very severe dry eye in the multivariate analysis, OR 2.079 (95% CI 1.096-3.941). Conclusion: Severe or very severe dry eye is associated with the presence of inflammatory joint involvement in patients with pSS. These results suggest that a directed anamnesis including systemic comorbidities, such as the presence of inflammatory joint involvement or dry mouth in patients with dry eye, would be useful to suspect a pSS.
Utilisation of primary healthcare services by Sjögren's syndrome patients in the Community of Madrid and associated factors: a population-based cross-sectional study

Jaime Barrio-Cortes,Tomas Gómez-Gascón,Beatriz Benito-Sánchez,Maria Felicitas Domínguez-Berjón,Maria Dolores Esteban-Vasallo,Juan Pablo Chalco-Orrego,Esther F Vicente-Rabaneda,Chiara Baldini,Chiara Seghieri,Andreas V Goules,Dimitrios I Fotiadis,Athanasios G Tzioufas

DOI: https://doi.org/10.55563/clinexprheumatol/ne3r87

Abstract:Objectives: To describe the utilisation of primary health care (PHC) services and factors associated with its use by patients diagnosed with Sjögren's syndrome (SS). Methods: Population-based cross-sectional cohort of SS patients in Madrid, Spain (SIERMA). Sociodemographic, diagnostic, clinical and PHC service utilisation variables were studied by bivariate analyses and regression models. Results: A total of 4,778 SS patients were included, 65.2% classified as primary SS (pSS), while 34.8% associated with another autoimmune disease (associated SS). Mean age was 64.3 years, and 92.8% of the patients were women. A total of 87.5% used PHC services, with a mean of 19.8 consultations/year. The general practitioner was the most visited health professional, with a mean of 10.9 consultations/year, followed by the nurse, with a mean of 5.7. Characteristics associated with a greater use of PHC services in SS patients were associated SS, higher adjusted morbidity groups (AMG) risk level and older age. Additional factors included symptoms such as dry mouth, fatigue, dry vagina and joint and muscle pain; comorbidities such as atrial fibrillation, diabetes, hypertension, solid malignant neoplasms, coronary heart disease and chronic obstructive pulmonary disease; and treatments such as sterile saline solution, corticosteroids, opioids and biologic disease-modifying anti-rheumatic drugs. Conclusions: Most SS patients used PHC services during the study period, and the mean number of consultations was remarkably high. Utilisation was mainly associated with AMG risk level, ageing, glandular and extra-glandular symptoms, substantial comorbidities and various treatments. An optimised design of PHC policies will facilitate early diagnosis, improved management and better quality of life for SS patients.
Targeted saliva metabolomics in Sjögren's syndrome

Giovanna Piacenza Florezi,Felippe Pereira Barone,Mario Augusto Izidoro,José Maria Soares-Jr,Claudia Malheiros Coutinho-Camillo,Silvia Vanessa Lourenço

DOI: https://doi.org/10.1016/j.clinsp.2024.100459

2024-08-03

Abstract:Objective: Sjögren's Syndrome (SS) is a chronic inflammatory autoimmune exocrinopathy, and although, the role of metabolism in the autoimmune responses has been discussed in diseases such as lupus erythematosus, rheumatoid arthritis, psoriasis and scleroderma. There is a lack of information regarding the metabolic implications of SS. Considering that the disease affects primarily salivary glands; the aim of this study is to evaluate the metabolic changes in the salivary glands' microenvironment using a targeted metabolomics approach. Methods: The saliva from 10 patients diagnosed with SS by the American-European consensus and 10 healthy volunteers was analyzed in an Ultra-high Performance Liquid Chromatograph Coupled Mass Spectrometry (UPLC-MS). Results: The results showed an increased concentration in SS of metabolites involved in oxidative stress such as lactate, alanine and malate, and amino acids involved in the growth and proliferation of T-cells, such as arginine, leucine valine and isoleucine. Conclusions: These results revealed that is possible to differentiate the metabolic profile of SS and healthy individuals using a small amount of saliva, which in its turn may reflect the cellular changes observed in the microenvironments of damaged salivary glands from these patients.
Primary Sjögrens syndrome independently promotes premature subclinical atherosclerosis

Nadine Zehrfeld,Malin Abelmann,Sabrina Benz,Clara Luisa Zippel,Sonja Beider,Emelie Kramer,Tabea Seeliger,Georgios Sogkas,Vega Gödecke,Gerrit Ahrenstorf,Franz Paul Armbruster,Thomas Skripuletz,Torsten Witte,Anselm Arthur Derda,Kristina Sonnenschein,Diana Ernst

DOI: https://doi.org/10.1136/rmdopen-2023-003559

2024-04-26

RMD Open

Abstract:Objectives Cardiovascular comorbidities are common in patients with autoimmune diseases. This study investigates the extent of subclinical atherosclerosis in patients with primary Sjögren's syndrome (pSS). Correlations with clinical factors such as organ involvement (OI) or disease activity were analysed and oxLDL antibodies (oxLDL ab) were measured as potential biomarkers of vascular damage. Methods Patients with pSS were consecutively included from the rheumatology outpatient clinic. Age- and sex-matched controls were recruited (2:1 ratio). Data collection was performed by a standardised questionnaire and Doppler ultrasound to evaluate the plaque extent and carotid intima-media thickness (cIMT). Propensity score matching included all cardiovascular risk (CVR) factors and corresponding laboratory markers. Results Data were available for 299 participants (199 pSS/100 controls), aged 59.4 years (50.6–65.0), 19.1% male. After matching, the pSS cohort had greater cIMT (p<0.001) and plaque extent (OR=1.82; 95% CI 1.14 to 2.95). Subgroup analyses of patients with pSS revealed that OI was associated with increased cIMT (p=0.025) and increased plaque occurrence compared with patients without OI (OR=1.74; 95% CI 1.02 to 3.01). OxLDL ab tended to be lower in patients with plaque (p=0.052). Correlations of higher Oxidized Low Density Lipoprotein (oxLDL) ab with EULAR Sjögren's Syndrome Disease Activity Index (p<0.001) and anti–Sjögren's-syndrome-related antigen A autoantibodies (SSA/Ro antibodies) (p=0.026) were observed. Conclusions Subclinical atherosclerosis occurs earlier and more severely in patients with pSS. The difference in cIMT between pSS and controls seems mainly driven by patients with OI, suggesting that this subgroup is particularly at risk. OxLDL ab might protect against atherosclerotic progression in patients with pSS. CVR stratification and preventive medications such as Hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitors should be discussed and further longitudinal studies are needed.

rheumatology
Exposure to air pollution as an environmental determinant of how Sjögren's disease is expressed at diagnosis

Pilar Brito-Zerón,Alejandra Flores-Chávez,Wan-Fai Ng,Ildiko Fanny Horváth,Astrid Rasmussen,Roberta Priori,Chiara Baldini,Berkan Armagan,Burcugül Özkiziltaş,Sonja Praprotnik,Yasuori Suzuki,Luca Quartuccio,Gabriela Hernandez-Molina,Kerem Abacar,Elena Bartoloni,Maureen Rischmueller,Fabiola Reis-de Oliveira,Virginia Fernandes Moça Trevisani,Ciprian Jurcut,Cecilia Fugmann,Francesco Carubbi,Benedikt Hofauer,Valeria Valim,Sandra G Pasoto,Soledad Retamozo,Fabiola Atzeni,Eva Fonseca-Aizpuru,Miguel López-Dupla,Roberto Giacomelli,Hideki Nakamura,Miriam Akasbi,Kyle Thompson,Antónia Szántó,A Darise Farris,Martina Villa,Stefano Bombardieri,Levent Kilic,Abdurrahman Tufan,Katja Perdan Pirkmajer,Yuhei Fujisawa,Salvatore de Vita,Nevsun Inanc,Manuel Ramos-Casals,Sjögren Big Data Consortium,Xu Dong,Zhao Yan,Xiaomei Li,Li Wang,Peter Olsson,Thomas Mandl,Raphaele Seror,Xavier Mariette,Arjan Vissink,Hendrika Bootsma,Debashish Danda,Vasco C Romão,Matilde Bandeira,Manuel Silvério-António,Roser Solans,Carlos Galisteo,Demian Sene,David Isenberg,Paola Cipriani,Valerie Devauchelle,Tamer Gheita,Marcos Vázquez,Jacques Morel,Sandra Consani,S-K Kwok,S-H Park,Marika Kvarnstrom,Marie Wahren-Herlenius,P Ericka Díaz Cuiza,B E Herrera,Toshimasa Shimizu,Andrés González-García,Sheila Melchor-Díaz,Michele Bombardieri,Adrian Lees,Suzanne Arends,Elena Treppo,Simone Longhino,Valeria Manfrè,Maria Teresa Rizzo,Agata Sebastian,Piotr Wiland,Roberto Gerli,Sarah Downie-Doyle,Alain Saraux,Gunnel Nordmark,César Morcillo,Lluís González-de-Paz,Antoni Sisó-Almirall

DOI: https://doi.org/10.55563/clinexprheumatol/p1r1j4

Abstract:Objectives: To analyse how the potential exposure to air pollutants can influence the key components at the time of diagnosis of Sjögren's phenotype (epidemiological profile, sicca symptoms, and systemic disease). Methods: For the present study, the following variables were selected for harmonization and refinement: age, sex, country, fulfilment of 2002/2016 criteria items, dry eyes, dry mouth, and overall ESSDAI score. Air pollution indexes per country were defined according to the OECD (1990-2021), including emission data of nitrogen and sulphur oxides (NO/SO), particulate matter (PM2.5 and 1.0), carbon monoxide (CO) and volatile organic compounds (VOC) calculated per unit of GDP, Kg per 1000 USD. Results: The results of the chi-square tests of independence for each air pollutant with the frequency of dry eyes at diagnosis showed that, except for one, all variables exhibited p-values <0.0001. The most pronounced disparities emerged in the dry eye prevalence among individuals inhabiting countries with the highest NO/SO exposure, a surge of 4.61 percentage points compared to other countries, followed by CO (3.59 points), non-methane (3.32 points), PM2.5 (3.30 points), and PM1.0 (1.60 points) exposures. Concerning dry mouth, individuals residing in countries with worse NO/SO exposures exhibited a heightened frequency of dry mouth by 2.05 percentage points (p<0.0001), followed by non-methane exposure (1.21 percentage points increase, p=0.007). Individuals inhabiting countries with the worst NO/SO, CO, and PM2.5 pollution levels had a higher mean global ESSDAI score than those in lower-risk nations (all p-values <0.0001). When systemic disease was stratified according to DAS into low, moderate, and high systemic activity levels, a heightened proportion of individuals manifesting moderate/severe systemic activity was observed in countries with worse exposures to NO/SO, CO, and PM2.5 pollutant levels. Conclusions: For the first time, we suggest that pollution levels could influence how SjD appears at diagnosis in a large international cohort of patients. The most notable relationships were found between symptoms (dryness and general body symptoms) and NO/SO, CO, and PM2.5 levels.
Periodontal conditions in patients with Sjögren's syndrome: A meta-analysis

Shih-Yun Wu,Ching-Yi Wu,Ming-Han Chen,Hsin-Yi Huang,Yu-hsuan Chen,Yen-Po Tsao,Yu-Lin Lai,Shih-Yuan Lee

DOI: https://doi.org/10.1016/j.jds.2020.11.015

IF: 3.719

2021-10-01

Journal of Dental Sciences

Abstract:Sjögren's syndrome (SS) is a chronic autoimmune rheumatic disease characterized by a progressive lymphocytic infiltration of salivary glands, resulting in xerostomia and other oral diseases. The pathogenesis and mechanisms of SS on periodontal tissues are not well understood. Furthermore, results of two systemic reviews and meta-analyses in which compared periodontal parameters of patients with SS to healthy subjects were different. To determine whether periodontal conditions in SS were different from healthy controls, we re-examined the issue with a random-effect model, avoiding recruiting active controls and inadequate data conversion. Outcome measures included probing pocket depth (PPD), clinical attachment loss (CAL), plaque index (PI), and gingival index (GI). Recruited individuals comprised 198 patients with SS and 180 subjects for healthy controls. Quantitative analysis revealed higher PI (WMD = 0.76, 95% CI: 0.30, 1.23) and GI (WMD of total = 0.50, 95% CI: 0.01, 0.98) in SS patients who were not categorized into primary or secondary types of SS. PPD and CAL in SS patients was comparable with control subjects. However, heterogeneity was observed among included studies. Thus, results from this and previous analyses should be interpretated carefully, and a well-designed observational study regarding this issue should be conducted.

dentistry, oral surgery & medicine
Untargeted lipidomics reveals specific lipid abnormalities in Sjogren's syndrome

Jiawei Lu,Yunke Guo,Yan Lu,Wei Ji,Lili Lin,Wenjuan Qian,Wenjun Chen,Jue Wang,Xiangyu Lv,Mengying Ke,Deshun Kong,Qiuxiang Shen,Youjuan Zhu,Ping Liu,Jinfeng Su,Lu Wang,Yuhua Li,Pan Gao,Jinjun Shan,Shijia Liu

DOI: https://doi.org/10.1093/rheumatology/keaa456

2021-01-01

Rheumatology

Abstract:Objective: The relationship between serum lipid variations in SS and healthy controls was investigated to identify potential predictive lipid biomarkers. Methods: Serum samples from 230 SS patients and 240 healthy controls were collected. The samples were analysed by ultrahigh-performance liquid chromatography coupled with Q Exactive (TM) spectrometry. Potential lipid biomarkers were screened through orthogonal projection to latent structures discriminant analysis and further evaluated by receiver operating characteristic analysis. Results: A panel of three metabolites [phosphatidylcholine (18:0/22:5), triglyceride (16:0/18:0/18:1) and acylcarnitine (12:0)] was identified as a specific biomarker of SS. The receiver operating characteristic analysis showed that the panel had a sensitivity of 84.3% with a specificity of 74.8% in discriminating patients with SS from healthy controls. Conclusion: Our approach successfully identified serum biomarkers associated with SS patients. The potential lipid biomarkers indicated that SS metabolic disturbance might be associated with oxidized lipids, fatty acid oxidation and energy metabolism.
Sex hormones, body mass index, and related comorbidities associated with developing Sjögren's disease: a nested case-control study

Sara S McCoy,Scott Hetzel,Jeffrey J VanWormer,Christie M Bartels

DOI: https://doi.org/10.1007/s10067-022-06226-8

Abstract:Objective: Sjögren's disease (SjD), a highly female predominant systemic autoimmune disease, peaks in perimenopause. Prior studies lack details on timing or type of sex hormone exposure. We examined SjD risk using endogenous and exogenous hormone exposure and related comorbidities. Methods: We performed a retrospective case-control study of adult women, nested within a population cohort. Cases had SjD diagnosed by a rheumatology provider or two SjD diagnoses from a non-rheumatology provider with a positive anti-SSA antibody or salivary gland biopsy. Cases were age-matched to three SjD-free controls. We calculated modified composite estrogen scores (mCES) and collected demographics, comorbidities, and endogenous and exogenous hormone exposures. Risk ratios were adjusted for demographics. Results: Of 546 SjD cases and 1637 age-matched controls, mCES was not significantly associated with SjD in adjusted models. The top individual hormone exposures associated with SjD included estrogen replacement therapy (ERT; RR 1.78 [95% CI 1.47-2.14]), polycystic ovarian syndrome (1.65 [1.28-2.12]), and hysterectomy without bilateral oophorectomy (1.51 [1.13-2.03]). We identified comorbidities preceding SjD including fibromyalgia, pulmonary disease, diabetes, lymphoma, osteoporosis, peripheral vascular disease, and renal disease. Taking comorbidities into account, we developed a predictive model for SjD that included fibromyalgia (2.50 [1.93-3.25]), osteoporosis (1.84 [1.27-2.66]), hormone replacement therapy (HRT) (1.61 [1.22-2.12]), diabetes (0.27 [0.13-0.50]), and body mass index (BMI) (0.97 [0.95-0.99]). Conclusions: We report a novel algorithm to improve identifying patients at risk for SjD and describe sex hormone association with SjD. Finally, we report new comorbidities associated with SjD decrease, BMI and diabetes, and increase, lymphoma and osteoporosis.. Key Points •Given female predominance and typical perimenopausal onset, sex hormones should be considered when studying comorbidities in Sjögren's disease. •The top exposures associated with developing Sjögren's disease included fibromyalgia, osteoporosis, and use of hormone replacement therapy. Possible protective factors included prior diabetes and higher body mass index. •We used our newly identified exposures to generate a predictive algorithm, which has potential to improve diagnosis and pathogenic insights into Sjögren's disease.
Prevalence, severity, and predictors of dry eye and dry mouth in Chinese patients with primary Sjögren syndrome

Zhenyu Li,Ting Fu,Lin Li,Yafei Cui,Chen Dong,Jing Li,Zhifeng Gu

DOI: https://doi.org/10.1007/s10067-018-4233-9

Abstract:Dry eye and dry mouth are typical clinical symptoms of primary Sjögren's syndrome (pSS), yet not considered in the assessment of severity and predictors in China. This study aimed to investigate the prevalence, severity, and potential predictors of dry eye/dry mouth among Chinese pSS patients. A cross-sectional study was conducted from the Affiliated Hospital of Nantong University. A series of questionnaires were applied: Ocular Surface Disease Index (OSDI), EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI)-dry mouth items, fatigue severity scale (FSS), the 10 cm visual analog scale (VAS). Laboratory examinations were taken to obtain some biochemical indicators (i.e., C-reactive protein, erythrocyte sedimentation rate, anti-SSA/SSB antibody). Stepwise logistic/linear regression model was used to investigate the potential predictors of dry eye/dry mouth, respectively. Statistical analysis was performed using SPSS version 20.0. Two hundred twenty-four pSS patients were included in this study. Among them, 215 (95.98%) patients reported ESSPRI-dry mouth items score > 0, and the mean score was 4.92 ± 2.43. In addition, according to the score of OSDI, 84 (37.5%) subjects reported non-dry eye, whereas 140 (62.5%) subjects reported dry eye (44 mild, 31 moderate, 65 severe), and the mean of the total OSDI score was 25.01 ± 23.58. Then, using logistic regression and linear regression respectively, we found that age and fatigue were the potential predictors of dry eye, whereas dry mouth was predicted by age, fatigue, total pain, and ESR. The results of this study suggested that rheumatologists should pay attention to pSS patients' dry eye and dry mouth, especially those with older age, higher level of ESR, more severe fatigue, and pain.
Prevalence of Sjögren's syndrome in a closed rural community

U G Dafni,A G Tzioufas,P Staikos,F N Skopouli,H M Moutsopoulos

DOI: https://doi.org/10.1136/ard.56.9.521

Abstract:Objective: To define the prevalence of Sjögren's syndrome (SS) through an epidemiological survey in a closed rural community. The classification of SS is based on the validated criteria reported by a multicentre study performed in Europe and supported by the Epidemiology Committee of the European Community (EEC-COMAC Epidemiology). Methods: The population under study consisted of 837 women aged 18 years or older, residing in the Astakos community of Aitoloakarnania, Greece. The study protocol was subdivided in two parts. In part I, an exhaustive epidemiological survey of these women was conducted in July and August of 1992. The validated questionnaire used in the survey assesses both ocular and oral involvement. In part II, 45 of the women reporting symptoms of both dry eye and dry mouth were approached for a full examination based on the validated set of classification criteria of SS. The full complement of the diagnostic tests was performed on 35 of these women. A subject is classified as a definite primary SS case if at least four of six items of the subject's test items are positive. If three of six items are positive the subject is classified as a probable primary SS case. Results: The classification criteria for definite primary SS were satisfied by five women. This number corresponds to an estimated prevalence of 0.60% (exact 95% CI 0.19%, 1.39%). Probable primary SS was diagnosed for 25 women (prevalence = 2.99%). Conclusion: Because of the loss of follow up (10 of 45) and the use of slightly stricter criteria for inclusion of possible SS cases in part II of the study, we consider our estimate of the prevalence of SS to be conservative. This study concurring with other recent reports, suggests that SS is more prevalent than previously thought.
A Preliminary Study of the Oral Microbiota in Chinese Patients with Sjögren’s Syndrome

Miaoran Li,Yan Zou,Qian Jiang,Lindi Jiang,Qiang Yu,Xiaojun Ding,Youcheng Yu

DOI: https://doi.org/10.1016/j.archoralbio.2016.06.016

IF: 2.64

2016-01-01

Archives of Oral Biology

Abstract:Objective: To investigate the oral microbiota in Sjogren's syndrome (SS) as opposed to that of healthy subjects.Study design: Ten patients with primary SS, [6 patients daily taking stable dosage of hydroxychloroquine (HC) and 4 patients taking hydroxychloroquine combined with Prednisone acetas (HC + PA)], along with 10 age-matched healthy controls were examined in regard of number of teeth, stimulated/unstimulated saliva secretion rate. Microflora on bilateral buccal mucosa was analyzed by high throughput sequencing. Statistical analyses were performed using the chi-square test, t test and Mann-Whitney U test. The Venn diagrams and Redundancy Analysis (RDA) were also used to evaluate effects of the disease and treatment on the bacterial community composition.Results: The relative abundance of Proteobacteria in SS group was lower compared to controls (P=0.002). The total richness of genera for all groups was 339. The numbers of genera in SS group and in control group were 248 and 270, respectively. Some taxa with different prevalence and/or relative abundance were found between two groups.Conclusions: SS affects the oral microbiota and SS patients carry a different and less diverse microorganism community compared with healthy subjects. Prednisone acetas is an influence on the oral microbiome. This study provides a basic data on the oral flora in SS patients. (C) 2016 Elsevier Ltd. All rights reserved.
Characterization and risk estimate of cancer in patients with primary Sjögren syndrome

Pilar Brito-Zerón,,Belchin Kostov,Guadalupe Fraile,Daniel Caravia-Durán,Brenda Maure,Francisco-Javier Rascón,Mónica Zamora,Arnau Casanovas,Miguel Lopez-Dupla,Mar Ripoll,Blanca Pinilla,Eva Fonseca,Miriam Akasbi,Gloria de la Red,Miguel-Angel Duarte-Millán,Patricia Fanlo,Pablo Guisado-Vasco,Roberto Pérez-Alvarez,Antonio J. Chamorro,César Morcillo,Iratxe Jiménez-Heredia,Isabel Sánchez-Berná,Armando López-Guillermo,Manuel Ramos-Casals,

DOI: https://doi.org/10.1186/s13045-017-0464-5

2017-04-17

Abstract:BackgroundThe purpose of this study is to characterize the risk of cancer in a large cohort of patients with primary Sjögren syndrome (SjS).MethodsWe had analyzed the development of cancer in 1300 consecutive patients fulfilling the 2002 SjS classification criteria. The baseline clinical and immunological characteristics and systemic activity (ESSDAI scores) were assessed at diagnosis as predictors of cancer using Cox proportional hazards regression analysis adjusted for age at diagnosis and gender. The sex-and age-specific standardized incidence ratios (SIR) of cancer were estimated from 2012 Spanish mortality data.ResultsAfter a mean follow-up of 91 months, 127 (9.8%) patients developed 133 cancers. The most frequent type of cancer was B-cell lymphoma (including 27 MALT and 19 non-MALT B-cell lymphomas). Systemic activity at diagnosis of primary SjS correlated with the risk of hematological neoplasia and cryoglobulins with a high risk of either B-cell or non-B-cell lymphoma subtypes. Patients with cytopenias had a high risk of non-MALT B-cell and non-B-cell cancer, while those with low C3 levels had a high risk of MALT lymphomas and those with monoclonal gammopathy and low C4 levels had a high risk of non-MALT lymphomas. The estimated SIR for solid cancer was 1.13 and 11.02 for hematological cancer. SIRs for specific cancers were 36.17 for multiple myeloma and immunoproliferative diseases, 19.41 for Hodgkin lymphoma, 6.04 for other non-Hodgkin lymphomas, 5.17 for thyroid cancer, 4.81 for cancers of the lip and oral cavity, and 2.53 for stomach cancer.ConclusionsOne third of cancers developed by patients with primary SjS are B-cell lymphomas. The prognostic factors identified at SjS diagnosis differed according to the subtype of B-cell lymphoma developed. Primary SjS is also associated with the development of some non-hematological cancers (thyroid, oral cavity, and stomach).

oncology,hematology
POS0998-HPR THE EPIDEMIOLOGY OF PRIMARY SJOGREN’S SYNDROME: IS IT A RARE DISEASE?

E. Fusaro,M. Ditto,L. Lo Sardo,A. Migliardi,L. Brussino,R. Gnavi,S. Parisi,M. Dalmasso

DOI: https://doi.org/10.1136/annrheumdis-2023-eular.4394

IF: 27.973

2023-05-30

Annals of the Rheumatic Diseases

Abstract:Sjogren’s syndrome (SSj) is a systemic disease with autoimmune pathogenesis, with prevalent involvement of the lacrimal and salivary exocrine glands, classified as primary or secondary on the basis of the association with other rheumatic diseases.The epidemiological data in the literature are variable due to the heterogeneity of the populations examined and the different classification criteria used.In a recent systematic review by Baodon Qin et al. In a recent systematic review by Baodon Qin et al. the average incidence rate was 7 cases every 100,000 people/year (range 5-9) with higher values in the Caucasian and Asian populations, with a women/men ratio of 9.3 (95% CI 3.35 to 13.18), while the prevalence rate was 61 cases per 100,000 inhabitants (range 10-90) with a female/male ratio of 10.7 (95% CI 7.35-15.62).The aim of the study was to estimate the prevalence rate of primary SSj in real-life, through analysis of administrative data.An epidemiological research was carried out as at 31 December 2020, through the analysis of all adult patients residing in Piedmont (northwest of Italy) with exemption code (EC) for SSj (code 030) and any association with other ECs for rheumatological pathologies or for pathologies considered according to the 2016 EULAR/ACR classification criteria; specifically, the EC were considered for rheumatoid arthritis, ulcerative colitis and Crohn’s disease, chronic hepatitis (active), HIV infection, affected subjects from malignant neoplastic pathologies, tumors of uncertain behavior, systemic lupus erythematosus, Hashimoto’s thyroiditis, undifferentiated connective tissue disease; mixed cryoglobulinemia, antiphospholipid antibody syndrome (primary form), primary and familial amyloidosis, hereditary/familial autoinflammatory syndromes, microscopic polyangiitis, polyarteritis nodosa, sarcoidosis, dermatomyositis, polymyositis, mixed connective tissue disease, progressive systemic sclerosis.There were 3889 patients with EC for SSj as at 31 December 2020, of which 2611 with active EC.The number of assisted people alive with the aforementioned exemption was 2601, while those with other exemptions in the list were 1020. Of these patients, 1581 had only the exemption from code 030 as at 31 December 2020; the distribution of the other pathologies analyzed is shown in the tables below (Table 1).Of the total number of patients with active exemption, 2442 were female, while 159 were male, with a female/male ratio of 15.3; the distribution by gender is shown in Figure 1.Considering that the Piedmont population on 31 December 2020 was 4 274 945 inhabitants (ref: National Institute of Statistics), the estimated prevalence rate was 4.7 cases per 10 000 inhabitants.Table 1.Distribution of EC in patients residing in Piedmont as at 31/12/2020Diseases with ECN of patientsRheumatoid Arthritis250Ulcerative colitis and Crohn’s disease18chronic hepatitis52HIV infection2Systemic Lupus Erythematosus122Subjects affected by malignant neoplastic pathologies330Hashimoto’s thyroiditis280Undifferentiated Connective Tissue Sisease86Mixed Cryoglobulinemia6Antiphospholipid Antibody Syndrome8Primary And Familial Amyloidosis3Hereditary/Familial Autoinflammatory Syndromes1Microscopic Polyangiitis2Polyarteritis Nodosa1Sarcoidosis5Dermatomyositis2Polymyositis5Mixed connective tissue disease25Progressive systemic sclerosis56Figure 1.Distribution by gender of patients residing in Piedmont with exemption for Sjogren’s Syndrome. F: Female; M: MaleThis research has some limitations, including the retrospective design and the use of administrative data which may be affected by the aforementioned difficulty of classification as well as incorrect attributions of exemption, both for SSj and for associated pathologies.Our research highlights a number of patients with primary SSj lower than the prevalence figure that defines a rare disease, i.e. a prevalence of less than 5 cases per 10,000 inhabitants.Further studies are needed to confirm these preliminary data.[1]Baodong Qin et al. Ann Rheum Dis. 2015 Nov;74(11):1983-9.NIL.None Declared.

Medicine
Mortality in Patients with Primary Sjögren’s Syndrome: a Systematic Review and Meta-Analysis

Hong Huang,Wenhui Xie,Yan Geng,Yong Fan,Zhuoli Zhang

DOI: https://doi.org/10.1093/rheumatology/keab364

2021-01-01

Rheumatology

Abstract:Objective It remains debated whether patients with primary Sjögren’s syndrome (pSS) are at greater risk of mortality. We aimed to determine the magnitude of all-cause mortality risk in patients with pSS compared with the general population through a systematic review and meta-analysis. Methods We searched PubMed, EMBASE and Cochrane Library for studies published from inception to October 2020. Stata meta-analysis software was used to calculate the pooled risk estimates for mortality (standardized mortality ratio, SMR). Results Our search identified 2796 articles, of which 14 studies with 14 584 patients were eventually included for the analysis. A total of 902 deaths were observed. Overall, we found a 1.46-fold increased risk of death in pSS patients when compared with the general population [meta-standardized mortality ratio (SMR): 1.46, 95% CI: 1.10, 1.93]. Subgroup analyses showed that mortality risks were higher in European countries (meta-SMR: 1.55, 95% CI: 1.04, 2.33), in retrospective studies (meta-SMR: 1.50, 95% CI: 1.09, 2.05), in studies based on referral cohorts (meta-SMR: 1.55, 95% CI: 1.04, 2.30), in studies that enrolled >500 patients (meta-SMR: 1.70, 95% CI: 1.11, 2.61) and in studies with follow-up time longer than 8 years (meta-SMR: 1.55, 95% CI: 0.87, 2.77). Significantly greater mortality risk was found in patients with older age, male gender, vasculitis, interstitial lung disease, low complements, positive anti-La/SSB and cryoglobulinaemia. Conclusion The existing data indicated ∼50% increase of mortality among patients with pSS compared with the general population. More attention should be paid to those patients with poor prognostic factors.

[Current place of anticoagulants, fibrinolytic and anti-aggregation agents in the prevention of thrombosis].

Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey

Metabolic syndrome in systemic lupus erythematosus patients under Mediterranean diet

Mortality risk factors in primary Sjögren syndrome: a real-world, retrospective, cohort study

Lower Multiple Sclerosis Severity Score Is Associated with Higher Adherence to Mediterranean Diet in Subjects with Multiple Sclerosis from Northwestern Italy

Adherence to Mediterranean diet and subjective cognitive function in men

Vitamin D in Primary Sjogren's Syndrome (pSS) and the Identification of Novel Single-Nucleotide Polymorphisms Involved in the Development of pSS-Associated Diseases

Factors associated with severe dry eye in primary Sjögren's syndrome diagnosed patients

Utilisation of primary healthcare services by Sjögren's syndrome patients in the Community of Madrid and associated factors: a population-based cross-sectional study

Targeted saliva metabolomics in Sjögren's syndrome

Primary Sjögrens syndrome independently promotes premature subclinical atherosclerosis

Exposure to air pollution as an environmental determinant of how Sjögren's disease is expressed at diagnosis

Periodontal conditions in patients with Sjögren's syndrome: A meta-analysis

Untargeted lipidomics reveals specific lipid abnormalities in Sjogren's syndrome

Sex hormones, body mass index, and related comorbidities associated with developing Sjögren's disease: a nested case-control study

Prevalence, severity, and predictors of dry eye and dry mouth in Chinese patients with primary Sjögren syndrome

Prevalence of Sjögren's syndrome in a closed rural community

A Preliminary Study of the Oral Microbiota in Chinese Patients with Sjögren’s Syndrome

Characterization and risk estimate of cancer in patients with primary Sjögren syndrome

POS0998-HPR THE EPIDEMIOLOGY OF PRIMARY SJOGREN’S SYNDROME: IS IT A RARE DISEASE?

Mortality in Patients with Primary Sjögren’s Syndrome: a Systematic Review and Meta-Analysis